XML 44 R36.htm IDEA: XBRL DOCUMENT v3.23.2
Sale of Freeline Therapeutics GmbH - Additional Information (Details)
$ in Thousands
6 Months Ended
Feb. 08, 2023
USD ($)
Employees
Jun. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Gain on sale of Freeline Therapeutics GmbH   $ 20,279  
Restructuring charges   1,276  
Prepaid expenses and other current assets   6,385 $ 6,235
Prepaid Expenses      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
FTE costs paid   2,600  
Freeline Therapeutics Gmbh      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Aggregate cash purchase price $ 25,218    
Gain on sale of Freeline Therapeutics GmbH 20,279    
Foreign currency translation losses $ 200    
Number of full-time employee equivalents | Employees 15    
Prepaid expenses and other current assets   800  
Committed payments under services agreement for next year   $ 3,100 4,800
Committed payments under services agreement for year two     $ 3,100
Freeline Therapeutics Gmbh | Minimum      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Restructuring charges $ 7,900